[NBIX] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
09-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -75.39%
YoY- -306.59%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 237,100 138,403 71,086 0 15,000 19,769 0 -
PBT 38,900 -102,594 -41,818 -78,326 -19,264 -1,192 -11,842 -
Tax 1,500 -479 7,504 -1,606 -1,593 -1,340 -1,061 -
NP 37,400 -102,115 -41,818 -78,326 -19,264 -1,192 -11,842 -
Tax Rate -3.86% - - - - - - -
Total Cost 199,700 240,518 112,904 78,326 34,264 20,961 11,842 60.06%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 15.77 -73.78 -58.83 0.00 -128.43 -6.03 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS 0.40 -1.12 -0.47 -0.90 -0.22 -0.01 -0.17 -
EPS Diluted 0.39 -1.12 -0.47 -0.90 -0.22 -0.01 -0.17 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.